Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) Other Current Receivables: ¥7.7 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920273 Hubei Yizhi Konjac Biotechnology Co Ltd BJSE:920273
73 GF Score
Price ¥19.99
GF Value ¥15.45
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Hubei Yizhi Konjac Biotechnology Co Other Current Receivables?

Hubei Yizhi Konjac Biotechnology Co BJSE:920273 73 Other Current Receivables is ¥7.7 Mil as of Jun. 2026. GuruFocus rates BJSE:920273 with a GF Score™ of 73/100 and a GF Value™ of ¥15.45 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Hubei Yizhi Konjac Biotechnology Co's Other Current Receivables for the quarter that ended in Jun. 2026 was ¥7.7 Mil.

Hubei Yizhi Konjac Biotechnology Co's quarterly Other Current Receivables declined from Dec. 2025 (¥6.62 Mil) to Mar. 2026 (¥6.35 Mil) but then increased from Mar. 2026 (¥6.35 Mil) to Jun. 2026 (¥7.71 Mil).

Hubei Yizhi Konjac Biotechnology Co's annual Other Current Receivables declined from Dec. 2023 (¥9.86 Mil) to Dec. 2024 (¥5.91 Mil) but then increased from Dec. 2024 (¥5.91 Mil) to Dec. 2025 (¥6.62 Mil).

Hubei Yizhi Konjac Biotechnology Co Other Current Receivables Related Terms

Hubei Yizhi Konjac Biotechnology Co Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Hubei Yizhi Konjac Biotechnology Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Yizhi Konjac Biotechnology Co Other Current Receivables Chart

Hubei Yizhi Konjac Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.92 5.61 9.86 5.91 6.62

Hubei Yizhi Konjac Biotechnology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.45 9.80 6.62 6.35 7.71
BJSE:920273
73GF Score
Hubei Yizhi Konjac Biotechnology Co Ltd BJSE:920273
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hubei Yizhi Konjac Biotechnology Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ¥7.7 Mil mean?
Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) has a Other Current Receivables of ¥7.7 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Hubei Yizhi Konjac Biotechnology Co and its competitors.
Is Hubei Yizhi Konjac Biotechnology Co's Other Current Receivables too high?
Hubei Yizhi Konjac Biotechnology Co's current Other Current Receivables is ¥7.7 Mil. Overall, Hubei Yizhi Konjac Biotechnology Co has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hubei Yizhi Konjac Biotechnology Co's Other Current Receivables compare to VRTX and REGN?
Hubei Yizhi Konjac Biotechnology Co's Other Current Receivables of ¥7.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Hubei Yizhi Konjac Biotechnology Co and its competitors. Hubei Yizhi Konjac Biotechnology Co's current Other Current Receivables is ¥7.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Yizhi Konjac Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥15.45, compared to a current price of ¥19.99 — trading 29.4% above its estimated fair value. The current Other Current Receivables is ¥7.7 Mil. Hubei Yizhi Konjac Biotechnology Co's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Hubei Yizhi Konjac Biotechnology Co (BJSE:920273), the current Other Current Receivables is ¥7.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) Overvalued in 2026?

Based on GuruFocus' analysis, Hubei Yizhi Konjac Biotechnology Co stock appears to be overvalued. The current stock price of ¥19.99 is trading 29.4% above its estimated GF Value™ of ¥15.45. GuruFocus considers Hubei Yizhi Konjac Biotechnology Co to be Modestly Overvalued.

Key valuation signals for BJSE:920273:

  • Other Current Receivables: ¥7.7 Mil
  • GF Value™: ¥15.45 vs. price of ¥19.99 (29.4% above fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the BJSE:920273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hubei Yizhi Konjac Biotechnology Co Business Description

Address No. 438, Changyang Avenue, Changyang Economic Development Zone, Hubei Province, Yichang City, CHN, 443500
Hubei Yizhi Konjac Biotechnology Co Ltd is a biotechnology enterprise specializing in the deep processing of konjac. It engages in research and development, production, and sales of konjac-intensive processing and konjac-related products. It has three product categories of konjac gum, konjac food, and konjac tools and nearly 66 product series.
73GF Score

Get the complete analysis for BJSE:920273

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.99
Price
¥15.45
GF Value